A chemically‐modified inactive antithrombin as a potent antagonist of fondaparinux and heparin anticoagulant activity

Fazavana, J. ; Bianchini, E. P. ; Saller, F. ; Smadja, C. ; Picard, V. ; Taverna, M. ; Borgel, D.

Journal of thrombosis and haemostasis, 2013-06, Vol.11 (6), p.1128-1136 [Periódico revisado por pares]

England: Wiley Subscription Services, Inc

Texto completo disponível